Conferences

November 15, 2024

New study shows IVIG replacement lowers infection risk in CLL and NHL patients, highlighting the need for better IgG testing and IgRT guidelines.

July 15, 2024

The bispecific antibody epcoritamab (Epkinly) was recently FDA-approved for the treatment of relapsed/refractory follicular lymphoma. Find out more!

July 09, 2024

First results of golcadomide, a new CELMoD, in monotherapy and with rituximab relapsed/refractory follicular lymphoma (non-Hodgkin Lymphoma) by Dr. Chavez.

May 27, 2024

The American Society of Clinical Oncology holds a yearly conference in June to allow researchers and doctors in the cancer community an opportunity to share…

May 06, 2024

Discover Evorpacept: A Next-Generation CD47 Checkpoint Inhibitor For Cancer Treatment with Enhanced Safety and Efficacy.

March 11, 2024

Dr. Nnawub shared research about how the type of insurance a patient has impacts their survival outcomes and the quality of care they receive.

December 27, 2023

Dr. Johnson speaks to HealthTree about the potential impact of a specially designed educational video for patient care.

December 22, 2023

Dr. Alderuccio presents the initial results of a phase II clinical trial for high-risk follicular lymphoma patients.

December 12, 2023

Dr. Strati is working on a non-chemotherapy based treatment option for newly diagnosed follicular lymphoma patients with advanced disease.

December 01, 2023

The American Society of Hematology holds a yearly conference in December to allow researchers and doctors in the cancer community an opportunity to...